Evidence map›Paper›PMID 37018843›Full record

ReviewAnnual review of biochemistry2023

The Design and Application of DNA-Editing Enzymes as Base Editors.

Kartik L Rallapalli, Alexis C Komor

Abstract readReview
In one paragraph

Review in Annual review of biochemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Collapsing retroviruses for efficient delivery of viro-toxic cargoes.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Gene Therapy Techniques and Delivery Methods (Review).Sovremennye tekhnologii v meditsine · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kartik L RallapalliDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California, USA; email: akomor@ucsd.edu.
Alexis C KomorDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California, USA; email: akomor@ucsd.edu.

Funding

Supplement to R35 "Development and Application of New Genome Editing Tools for the Functional Investigation of Genetic Variants of Uncertain Significance"R35GM138317 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Alexis C. Komor · 2020 to 2026
$2.8M
NIGMS NIH HHS R35 GM138317
6 · The paper itself

Abstract

DNA-editing enzymes perform chemical reactions on DNA nucleobases. These reactions can change the genetic identity of the modified base or modulate gene expression. Interest in DNA-editing enzymes has burgeoned in recent years due to the advent of clustered regularly interspaced short palindromic repeat-associated (CRISPR-Cas) systems, which can be used to direct their DNA-editing activity to specific genomic loci of interest. In this review, we showcase DNA-editing enzymes that have been repurposed or redesigned and developed into programmable base editors. These include deaminases, glycosylases, methyltransferases, and demethylases. We highlight the astounding degree to which these enzymes have been redesigned, evolved, and refined and present these collective engineering efforts as a paragon for future efforts to repurpose and engineer other families of enzymes. Collectively, base editors derived from these DNA-editing enzymes facilitate programmable point mutation introduction and gene expression modulation by targeted chemical modification of nucleobases.

Indexed as

CRISPR-Cas SystemsGene EditingCRISPR-Associated Protein 9DNAGenomeCRISPR-Associated Protein 9DNAbase editorsdeaminasesdemethylasesglycosylasesmethyltransferasesprotein engineering

Identifiers

PMID37018843
PMCPMC10330504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.